SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-24-000245
Filing Date
2024-03-20
Accepted
2024-03-20 16:06:43
Documents
60
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K enzn-20231231x10k.htm   iXBRL 10-K 792600
2 EX-4.1 enzn-20231231xex4d1.htm EX-4.1 40651
3 EX-21.1 enzn-20231231xex21d1.htm EX-21.1 4076
4 EX-23.1 enzn-20231231xex23d1.htm EX-23.1 4489
5 EX-31.1 enzn-20231231xex31d1.htm EX-31.1 14962
6 EX-32.1 enzn-20231231xex32d1.htm EX-32.1 6470
  Complete submission text file 0001410578-24-000245.txt   3798107

Data Files

Seq Description Document Type Size
7 EX-101.SCH enzn-20231231.xsd EX-101.SCH 34700
8 EX-101.CAL enzn-20231231_cal.xml EX-101.CAL 29646
9 EX-101.DEF enzn-20231231_def.xml EX-101.DEF 125347
10 EX-101.LAB enzn-20231231_lab.xml EX-101.LAB 266507
11 EX-101.PRE enzn-20231231_pre.xml EX-101.PRE 213538
64 EXTRACTED XBRL INSTANCE DOCUMENT enzn-20231231x10k_htm.xml XML 387352
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12957 | Film No.: 24767818
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)